{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T23:06:20Z","timestamp":1749164780410,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00108-021-01155-1","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:23:44Z","timestamp":1630452224000},"page":"1123-1132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toxoplasma gondii\u00a0\u2013 gegenw\u00e4rtige Arzneimittel und zuk\u00fcnftige Impfstoffe gegen eine untersch\u00e4tzte Protozoonose","Toxoplasma gondii\u2014Current drugs and future vaccines against an underestimated protozoan infection"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-6985","authenticated-orcid":false,"given":"Yannick","family":"Borkens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"1155_CR1","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2147\/IJN.S122178","volume":"12","author":"OS Adeyemi","year":"2017","unstructured":"Adeyemi\u00a0OS, Murata\u00a0Y, Sugi\u00a0T, Kato\u00a0K (2017) Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential. Int J Nanomed 12:1647\u20131661","journal-title":"Int J Nanomed"},{"issue":"2","key":"1155_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.7589\/2019-06-155","volume":"56","author":"S Ammar","year":"2020","unstructured":"Ammar\u00a0S, Purple\u00a0K, Gerhold\u00a0R (2020) Toxoplasma gondii prevalence in hunter-killed mourning doves (Zenaida macroura) and rock pigeons (Columba livia) from East Tennessee, USA. J\u00a0Wildl Dis 56(2):479\u2013481","journal-title":"J Wildl Dis"},{"key":"1155_CR3","unstructured":"anses (2016) Toxoplasmose. https:\/\/www.anses.fr\/fr\/content\/toxoplasmose. Zugegriffen: 13. Juni 2021"},{"issue":"4","key":"1155_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd3012","volume":"9","author":"RD Astronomo","year":"2010","unstructured":"Astronomo\u00a0RD, Burton\u00a0DR (2010) Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov 9(4):308\u2013324","journal-title":"Nat Rev Drug Discov"},{"key":"1155_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s13071-020-04445-z","volume":"13","author":"M Attias","year":"2020","unstructured":"Attias\u00a0M, Teixeira\u00a0DE, Benchimol\u00a0M, Vommaro\u00a0RC, Crepaldi\u00a0PH, De Souza\u00a0W (2020) The life-cycle of Toxoplasma gondii reviewed using animations. Parasites Vectors 13:588","journal-title":"Parasites Vectors"},{"key":"1155_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3389\/fcimb.2018.00300","volume":"8","author":"MJ Bai","year":"2018","unstructured":"Bai\u00a0MJ, Wang\u00a0JL, Elsheikha\u00a0HM, Liang\u00a0QL, Chen\u00a0K, Nie\u00a0LB, Zhu\u00a0XQ (2018) Functional characterization of dense granule proteins in Toxoplasma gondii RH strain using CRISPR-Cas9 system. Front Cell Infect Microbiol 8:300","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"1155_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/2229-5070.190817","volume":"6","author":"A Basavaraju","year":"2016","unstructured":"Basavaraju\u00a0A (2016) Toxoplasmosis in HIV infection: An overview. Trop Parasitol 6(2):129\u2013135","journal-title":"Trop Parasitol"},{"issue":"8","key":"1155_CR8","first-page":"317","volume":"43","author":"Y Borkens","year":"2020","unstructured":"Borkens\u00a0Y (2020) Ist eine Malaria-Impfung m\u00f6glich? \u2013 Verschiedene Impfkandidaten und ihr Potenzial gegen Plasmodium-Parasiten. Med Monatsschr Pharm 43(8):317\u2013321","journal-title":"Med Monatsschr Pharm"},{"key":"1155_CR9","unstructured":"CDC\u2019s Division of Parasitic Diseases and Malaria, DPDx (2020) Parasites\u2014Toxoplasmosis (Toxoplasma infection): Biology. https:\/\/www.cdc.gov\/parasites\/toxoplasmosis\/biology.html. Zugegriffen: 19. Mai 2021"},{"key":"1155_CR10","unstructured":"CDC\u2019s Division of Parasitic Diseases and Malaria, DPDx (2018) Parasites\u2014toxoplasmosis (Toxoplasma infection): epidemiology & risk factors. https:\/\/www.cdc.gov\/parasites\/toxoplasmosis\/epi.html#:~:text=Toxoplasmosis%20is%20caused%20by%20the,have%20been%20infected%20with%20Toxoplasma. Zugegriffen: 25. Mai 2021"},{"key":"1155_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.4269\/ajtmh.16-0548","volume":"96","author":"XT Ching","year":"2017","unstructured":"Ching\u00a0XT, Fong\u00a0MY, Lau\u00a0YL (2017) Evaluation of the protective effect of deoxyribonucleic acid vaccines encoding granule antigen 2 and 5 against acute toxoplasmosis in BALB\/c mice. Am J Trop Med Hyg 96:1441\u20131447","journal-title":"Am J Trop Med Hyg"},{"key":"1155_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/vaccines9050413","volume":"9","author":"KB Chu","year":"2021","unstructured":"Chu\u00a0KB, Quan\u00a0FS (2021) Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development. Vaccines 9:413","journal-title":"Vaccines"},{"key":"1155_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bmj.321.7254.142","volume":"15","author":"AJ Cook","year":"2000","unstructured":"Cook\u00a0AJ, Gilbert\u00a0RE, Buffolano\u00a0W, Zufferey\u00a0J, Petersen\u00a0E, Jenum\u00a0PA, Foulon\u00a0W, Semprini\u00a0AE, Dunn\u00a0DT (2000) Sources of Toxoplasma infection in pregnant women: European multi centre case-control study. European Research Network on congenital Toxoplasmosis. BMJ 15:142\u2013147","journal-title":"BMJ"},{"key":"1155_CR14","unstructured":"Deutschlandfunk (2008) Medizin: Ein Malaria-Medikament hilft gegen Toxoplasmose. https:\/\/www.deutschlandfunk.de\/meldungen-liste-forschung-aktuell.1508.de.html?drn:news_id=83868. Zugegriffen: 23. Apr. 2021"},{"key":"1155_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biomaterials.2015.01.056","volume":"50","author":"L Dimier-Poisson","year":"2015","unstructured":"Dimier-Poisson\u00a0L, Carpentier\u00a0R, N\u2019Guyen\u00a0TT, Dahmani\u00a0F, Ducournau\u00a0C, Berbeder\u00a0D (2015) Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection. Biomaterials 50:164\u2013175","journal-title":"Biomaterials"},{"key":"1155_CR16","first-page":"93","volume":"2","author":"JP Dubey","year":"1984","unstructured":"Dubey\u00a0JP (1984) Experimental toxoplasmosis in sheep fed Toxoplasma gondii oocysts. Int Goat Sheep Res 2:93\u2013104","journal-title":"Int Goat Sheep Res"},{"key":"1155_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2460\/ajvr.1991.52.08.1316","volume":"52","author":"JP Dubey","year":"1991","unstructured":"Dubey\u00a0JP, Urban\u00a0JF Jr., Davis\u00a0SW (1991) Protective immunity to toxoplasmosis in pigs vaccinated with a\u00a0nonpersistent strain of Toxoplasma gondii. Am J Vet Res 52:1","journal-title":"Am J Vet Res"},{"issue":"7","key":"1155_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0020-7519(98)00023-X","volume":"28","author":"JP Dubey","year":"1998","unstructured":"Dubey\u00a0JP (1998) Advances in the life cycle of Toxoplasma gondii. Int J Parasitol 28(7):1019\u20131024","journal-title":"Int J Parasitol"},{"key":"1155_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41541-017-0024-6","volume":"2","author":"K El Bissati","year":"2017","unstructured":"El Bissati\u00a0K, Zhou\u00a0Y, Paulillo\u00a0SM, Raman\u00a0SK, Karch\u00a0CP, Roberts\u00a0CW, Lanar\u00a0DE, Reed\u00a0S, Fox\u00a0C, Carter\u00a0D, Alexander\u00a0J, Sette\u00a0A, Sidney\u00a0J, Lorenzi\u00a0H, Begeman\u00a0IJ, Burkhard\u00a0P, McLeod\u00a0R (2017) Protein nanovaccine confers robust immunity against Toxoplasma. NPJ Vaccines 2:24","journal-title":"NPJ Vaccines"},{"key":"1155_CR20","doi-asserted-by":"publisher","first-page":"16984","DOI":"10.1038\/s41598-020-73210-0","volume":"10","author":"K El Bissati","year":"2020","unstructured":"El Bissati\u00a0K, Zhou\u00a0Y, Paulillo\u00a0SM, Raman\u00a0SK, Karch\u00a0CP, Reed\u00a0S, Estes\u00a0A, Estes\u00a0A, Lykins\u00a0J, Burkhard\u00a0P, McLeod\u00a0R (2020) Engineering and characterization of a\u00a0novel self assembling protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice. Sci Rep 10:16984","journal-title":"Sci Rep"},{"issue":"4","key":"1155_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pt.2013.01.007","volume":"29","author":"J Flegr","year":"2013","unstructured":"Flegr\u00a0J (2013) How and why Toxoplasma makes us crazy. Trends Parasitol 29(4):156\u2013163","journal-title":"Trends Parasitol"},{"issue":"3","key":"1155_CR22","doi-asserted-by":"publisher","first-page":"e90203","DOI":"10.1371\/journal.pone.0090203","volume":"9","author":"J Flegr","year":"2014","unstructured":"Flegr\u00a0J, Prandota\u00a0J, Sovi\u010dkova\u00a0M, Israili\u00a0ZH (2014) Toxoplasmosis\u2014A global threat. Correlation of latent toxoplasmosis with specific disease burden in a\u00a0set of 88\u00a0countries. Plos One 9(3):e90203","journal-title":"Plos One"},{"key":"1155_CR23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2460\/ajvr.1991.52.05.759","volume":"52","author":"JK Frenkel","year":"1991","unstructured":"Frenkel\u00a0JK, Pfefferkorn\u00a0ER, Smith\u00a0DD, Fishback\u00a0JL (1991) Prospective vaccine prepared from a\u00a0new mutant of Toxoplasma gondii for use in cats. Am J Vet Res 52:759\u2013763","journal-title":"Am J Vet Res"},{"issue":"6","key":"1155_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/icb.1966.63","volume":"44","author":"DGA Gibb","year":"1966","unstructured":"Gibb\u00a0DGA, Kakulas\u00a0BA, Perret\u00a0DH, Jenkyn\u00a0DJ (1966) Toxoplasmosis in the rottnest quokka (Setonix brachyurus). Aust J Exp Biol Med Sci 44(6):665\u2013672","journal-title":"Aust J Exp Biol Med Sci"},{"key":"1155_CR25","unstructured":"Global Health, Division of Parasitic Diseases and Malaria (2018) Parasites\u2014Toxoplasmosis (Toxoplasma infection): Treatment. https:\/\/www.cdc.gov\/parasites\/toxoplasmosis\/treatment.html. Zugegriffen: 20. Aug. 2021"},{"issue":"9","key":"1155_CR26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/glycob\/cwv040","volume":"25","author":"S G\u00f6tze","year":"2015","unstructured":"G\u00f6tze\u00a0S, Reinhardt\u00a0A, Geissner\u00a0A, Azzouz\u00a0N, Tsai\u00a0YH, Kurucz\u00a0R, Var\u00f3n\u00a0SD, Seeberger\u00a0PH (2015) Investigation of the protective properties of glycosylphosphatidylinositol-based vaccine candidates in a\u00a0Toxoplasma gondii mouse challenge model. Glycobiology 25(9):984\u2013991","journal-title":"Glycobiology"},{"key":"1155_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2021.03.009","author":"F Ishtiaq","year":"2021","unstructured":"Ishtiaq\u00a0F, Swain\u00a0S, Kumar\u00a0SS (2021) Anopheles stephensi (Asian Malaria Mosquito). Trends Parasitol. https:\/\/doi.org\/10.1016\/j.pt.2021.03.009","journal-title":"Trends Parasitol."},{"key":"1155_CR28","unstructured":"Jenner E (1799) History of the inoculation of the Cow-Pox: Further observations on the Variol\u00e6 Vaccin\u00e6, or Cow-Pox. Med Phys\u00a0J 1(4):313\u2013318"},{"issue":"16","key":"1155_CR29","first-page":"502","volume":"3","author":"E Jenner","year":"1800","unstructured":"Jenner\u00a0E (1800) Dr. Jenner, on the Vaccine Inoculation. Med Phys\u00a0J 3(16):502\u2013503","journal-title":"Med Phys J"},{"issue":"4","key":"1155_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/aje\/154.4.357","volume":"154","author":"JL Jones","year":"2001","unstructured":"Jones\u00a0JL, Kruszon-Moran\u00a0D, Wilson\u00a0M, McQuillan\u00a0G, Navin\u00a0T, McAuley\u00a0JB (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154(4):357\u2013365","journal-title":"Am J Epidemiol"},{"key":"1155_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","volume":"31","author":"N Kushnir","year":"2012","unstructured":"Kushnir\u00a0N, Streatfield\u00a0SJ, Yusibov\u00a0V (2012) Virus-like particles as a\u00a0highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31:58\u201383","journal-title":"Vaccine"},{"key":"1155_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.actatropica.2016.08.025","volume":"164","author":"DH Lee","year":"2016","unstructured":"Lee\u00a0DH, Kim\u00a0AR, Lee\u00a0SH, Quan\u00a0FS (2016) Cross-protection induced by Toxoplasma gondii virus-like particle vaccine upon intraperitoneal route challenge. Acta Trop 164:77\u201383","journal-title":"Acta Trop"},{"key":"1155_CR33","doi-asserted-by":"publisher","first-page":"e0161231","DOI":"10.1371\/journal.pone.0161231","volume":"11","author":"DH Lee","year":"2016","unstructured":"Lee\u00a0DH, Lee\u00a0SH, Kim\u00a0AR, Quan\u00a0FS (2016) Virus-like nanoparticle vaccine confers protection against Toxoplasma gondii. PLoS ONE 11:e161231","journal-title":"PLoS ONE"},{"key":"1155_CR34","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.vaccine.2019.11.076","volume":"38","author":"D Le Roux","year":"2020","unstructured":"Le Roux\u00a0D, Djokic\u00a0V, Morisse\u00a0S, Chauvin\u00a0C, Dor\u00e9\u00a0V, Lagr\u00e9e\u00a0AC, Voisin\u00a0D, Villain\u00a0Y, Grasset-Chevillot\u00a0A, Boursin\u00a0F, Su\u00a0C, Perrot\u00a0S, Vall\u00e9e\u00a0I, Seche\u00a0E, Blaga\u00a0R (2020) Toxoplasma gondii live attenuated strain in the feline host. Vaccine 38:1457\u20131466","journal-title":"Vaccine"},{"key":"1155_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","volume":"18","author":"Y Li","year":"2018","unstructured":"Li\u00a0Y, Zhou\u00a0H (2018) Moving towards improved vaccines for Toxoplasma gondii. Expert Opin Biol Ther 18:273\u2013280","journal-title":"Expert Opin Biol Ther"},{"key":"1155_CR36","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1039\/C9NR08958F","volume":"12","author":"P Lung","year":"2020","unstructured":"Lung\u00a0P, Yang\u00a0J, Li\u00a0Q (2020) Nanoparticle formulated vaccines: opportunities and challenges. Nanoscale 12:5746\u20135763","journal-title":"Nanoscale"},{"issue":"2","key":"1155_CR37","doi-asserted-by":"publisher","first-page":"e20163860","DOI":"10.1542\/peds.2016-3860","volume":"139","author":"YA Maldonado","year":"2017","unstructured":"Maldonado\u00a0YA, Read\u00a0JS, Committee on infectious diseases (2017) Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics 139(2):e20163860","journal-title":"Pediatrics"},{"key":"1155_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gofs.2021.03.003","author":"L Mandelbrot","year":"2021","unstructured":"Mandelbrot\u00a0L, Kieffer\u00a0F, Wallon\u00a0M, Winer\u00a0N, Massardier\u00a0J, Picone\u00a0O, Fuchs\u00a0F, Benoist\u00a0G, Garcia-Meric\u00a0P, L\u2019Ollivier\u00a0C, Paris\u00a0L, Piarroux\u00a0R, Villena\u00a0I, Peyron\u00a0F (2021) Toxoplasmose pendant la grossesse: proposition actuelle de prise en charge pratique. Gynecol Obstet Fetil Senol. https:\/\/doi.org\/10.1016\/j.gofs.2021.03.003","journal-title":"Gynecol Obstet Fetil Senol"},{"key":"1155_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0167-5877(02)00057-0","volume":"55","author":"NE Mateus-Pinilla","year":"2002","unstructured":"Mateus-Pinilla\u00a0NE, Hannon\u00a0B, Weigel\u00a0RM (2002) A computer simulation of the prevention of the transmission of Toxoplasma gondii on swine farms using a\u00a0feline T. gondii vaccine. Prev Vet Med 55:17\u201336","journal-title":"Prev Vet Med"},{"key":"1155_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.12688\/f1000research.16825.2","volume":"8","author":"DH McDermott","year":"2019","unstructured":"McDermott\u00a0DH, Heusinkveld\u00a0LE, Zein\u00a0WM, Sen\u00a0HN, Marquessen\u00a0MM, Parta\u00a0M, Rosenzweig\u00a0SD, Fahle\u00a0GA, Keller\u00a0MD, Wiley\u00a0HE, Murphy\u00a0PM (2019) Case Report: Ocular toxoplasmosis in a\u00a0WHIM syndrome immunodeficiency patient [Version 2; peer review: 3 approved. F1000 Res 8:2. https:\/\/doi.org\/10.12688\/f1000research.16825.2","journal-title":"F1000 Res"},{"issue":"1","key":"1155_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/expr.1994.1054","volume":"79","author":"JR Mineo","year":"1994","unstructured":"Mineo\u00a0JR, Kasper\u00a0LH (1994) Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG\u20111 (P30). Exp Parasitol 79(1):11\u201320","journal-title":"Exp Parasitol"},{"issue":"4","key":"1155_CR42","first-page":"227","volume":"5","author":"R Mohabati","year":"2013","unstructured":"Mohabati\u00a0R, Babaie\u00a0J, Amiri\u00a0S, Talebzadeh\u00a0M, Fard-Esfahani\u00a0P, Darbouy\u00a0M, Golkar\u00a0M (2013) Expression and purification of recombinant ROP1 of Toxoplasma gondii in bacteria. Avicenna J Med Biotechnol 5(4):227\u2013233","journal-title":"Avicenna J. Med. Biotechnol."},{"issue":"9425","key":"1155_CR43","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya\u00a0JG, Liesenfeld\u00a0O (2004) Toxoplasmosis. Lancet 363(9425):1965\u20131976","journal-title":"Lancet"},{"issue":"3","key":"1155_CR44","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1371\/journal.pntd.0000190","volume":"2","author":"EJ Mui","year":"2008","unstructured":"Mui\u00a0EJ, Schiehser\u00a0GA, Milhous\u00a0WK, Hsu\u00a0H, Roberts\u00a0CW, Kirisits\u00a0M, Muench\u00a0S, Rice\u00a0D, Dubey\u00a0JP, Fowble\u00a0JW, Rathod\u00a0PK, Queener\u00a0SF, Liu\u00a0SR, Jacobus\u00a0DP, McLeod\u00a0R (2008) Novel Triazine JCP-2067\u2011B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl Trop Dis 2(3):e190","journal-title":"PLoS Negl Trop Dis"},{"key":"1155_CR45","first-page":"736","volume":"147","author":"C Nicolle","year":"1908","unstructured":"Nicolle\u00a0C, Manceaux\u00a0L (1908) Sur une infection a\u00a0corps de Leishman (ou organismes voisons) du gondi. C\u00a0R Acad Sci 147:736","journal-title":"C R Acad Sci"},{"key":"1155_CR46","first-page":"369","volume":"148","author":"C Nicolle","year":"1909","unstructured":"Nicolle\u00a0C, Manceaux\u00a0L (1909) Sur un protozaire nouveau du gondi. C\u00a0R Acad Sci 148:369","journal-title":"C R Acad Sci"},{"issue":"7","key":"1155_CR47","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ijpara.2019.01.005","volume":"49","author":"M Opsteegh","year":"2019","unstructured":"Opsteegh\u00a0M, Spano\u00a0F, Aubert\u00a0D, Balea\u00a0A, Burrells\u00a0A, Cherchi\u00a0S, Cornelissen\u00a0JBWJ, Dam-Deisz\u00a0C, Guitian\u00a0J, Gy\u00f6rke\u00a0A, Innes\u00a0EA, Katzer\u00a0F, Limon\u00a0G, Possenti\u00a0A, Pozio\u00a0E, Schares\u00a0G, Villena\u00a0I, Wisselink\u00a0HJ, van der Giessen\u00a0JWB (2019) The relationship between the presence of antibodies and direct detection of Toxoplasma gondii in slaughtered calves and cattle in four European countries. Int J Parasitol 49(7):515\u2013522","journal-title":"Int J Parasitol"},{"key":"1155_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/978-3-8274-2734-2","volume-title":"W\u00f6rterbuch der Zoologie","author":"A Paululat","year":"2011","unstructured":"Paululat\u00a0A, Purschke\u00a0G (2011) Toxoplasma. In: Paululat\u00a0A, Purschke\u00a0G (Hrsg) W\u00f6rterbuch der Zoologie, 8.\u00a0Aufl. Spektrum Akademischer Verlag, Osnabr\u00fcck, S\u00a0461","edition":"8"},{"key":"1155_CR49","unstructured":"Pearson RD (2019) Toxoplasmose. https:\/\/www.msdmanuals.com\/de-de\/profi\/infektionskrankheiten\/extraintestinale-protozoen\/toxoplasmose. Zugegriffen: 10. Juni 2021"},{"key":"1155_CR50","first-page":"435","volume":"116","author":"U Pleyer","year":"2019","unstructured":"Pleyer\u00a0U, Gross\u00a0U, Schl\u00fcter\u00a0D, Wilking\u00a0H, Seeber\u00a0F (2019) Toxoplasmosis in Germany\u2014epidemiology, diagnosis, risk factors, and treatment. Dtsch Arztebl Int 116:435\u2013444","journal-title":"Dtsch Arztebl Int"},{"key":"1155_CR51","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41598-018-37671-8","volume":"9","author":"C Ramakrishnan","year":"2019","unstructured":"Ramakrishnan\u00a0C, Maier\u00a0S, Walker\u00a0RA, Rehrauer\u00a0H, Joekel\u00a0DE, Winiger\u00a0RR, Basso\u00a0WU, Grigg\u00a0ME, Hehl\u00a0AB, Deplazes\u00a0P, Smith\u00a0NC (2019) An experimental genetically attenuated live vaccine to prevent transmission of Toxoplasma gondii by cats. Sci Rep 9:1474","journal-title":"Sci Rep"},{"key":"1155_CR52","unstructured":"Robert Koch-Institut (2018) Toxoplasmose: RKI-Ratgeber. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_Toxoplasmose.html. Zugegriffen: 20. Aug. 2021"},{"key":"1155_CR53","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3389\/fmicb.2016.00808","volume":"7","author":"P Sonaimuthu","year":"2016","unstructured":"Sonaimuthu\u00a0P, Ching\u00a0XT, Fong\u00a0MY, Kalyanasundaram\u00a0R, Lau\u00a0YL (2016) Induction of protective immunity against Toxoplasmosis in BALB\/c mice vaccinated with Toxoplasma gondii Rhoptry\u20111. Front Microbiol 7:808","journal-title":"Front Microbiol"},{"key":"1155_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1071\/WR9830089","volume":"10","author":"R Speare","year":"1983","unstructured":"Speare\u00a0R, Beveridge\u00a0I, Johnson\u00a0PM, Corner\u00a0LA (1983) Parasites of the agile wallaby, macropus agilis (Marsupialia). Aust Wildl Res 10:89\u201396","journal-title":"Aust Wildl Res"},{"key":"1155_CR55","first-page":"109","volume":"3","author":"A Splendore","year":"1908","unstructured":"Splendore\u00a0A (1908) Un nuovo protozoa parassita deconigli incontrato nelle lesioni anatomiche d\u2019une malattia che ricorda in molti punti il Kala-azar dell\u2019uoma. Nota preliminare pel. Rev Soc Sci Sao Paulo 3:109\u2013112","journal-title":"Rev Soc Sci Sao Paulo"},{"key":"1155_CR56","first-page":"28","volume-title":"K\u00fckenthal: Zoologisches Praktikum","author":"V Storch","year":"2014","unstructured":"Storch\u00a0V, Welsch\u00a0U (2014) Protozoa, Einzellige Tiere III: Apicomplexa (=Sporozoa i.e.s.). In: Storch\u00a0V, Welsch\u00a0U (Hrsg) K\u00fckenthal: Zoologisches Praktikum, 27.\u00a0Aufl. Springer Spektrum, Wiesbaden, S\u00a028\u201335","edition":"27"},{"key":"1155_CR57","first-page":"46","volume-title":"Das Toxoplasmose Handbuch: Ein Parasit t\u00e4uscht die Medizin und macht uns krank \u2013 die aktive Toxoplasmose erkennen und behandeln","author":"auf der Stra\u00dfe U","year":"2019","unstructured":"auf der Stra\u00dfe U (2019) Die Symptome einer aktiven Toxoplasmose. In: auf der Stra\u00dfe U (Hrsg) Das Toxoplasmose Handbuch: Ein Parasit t\u00e4uscht die Medizin und macht uns krank \u2013 die aktive Toxoplasmose erkennen und behandeln, 2.\u00a0Aufl. BoD \u2013 Books on Demand, Norderstedt, S\u00a046\u201349","edition":"2"},{"issue":"4","key":"1155_CR58","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.2353\/ajpath.2010.090825","volume":"176","author":"Y Suzuki","year":"2010","unstructured":"Suzuki\u00a0Y, Wang\u00a0X, Jortner\u00a0BS, Payne\u00a0L, Ni\u00a0Y, Michie\u00a0SA, Xu\u00a0B, Kudo\u00a0T, Perkins\u00a0S (2010) Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol 176(4):1607\u20131613","journal-title":"Am J Pathol"},{"key":"1155_CR59","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2147\/IJN.S158736","volume":"13","author":"A Teimouri","year":"2018","unstructured":"Teimouri\u00a0A, Azami\u00a0SJ, Keshvaraz\u00a0H, Esmaeili\u00a0F, Alimi\u00a0R, Mavi\u00a0SA, Shojaee\u00a0S (2018) Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomed 13:1341\u20131351","journal-title":"Int J Nanomed"},{"key":"1155_CR60","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter\u00a0AM, Heckeroth\u00a0AR, Weiss\u00a0LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30:1217\u20131258","journal-title":"Int J Parasitol"},{"issue":"11","key":"1155_CR61","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00347-008-1694-2","volume":"105","author":"N Torun","year":"2008","unstructured":"Torun\u00a0N, Sherif\u00a0Z, Garweg\u00a0J, Pleyer\u00a0U (2008) Diagnostik und Behandlung der okul\u00e4ren Toxoplasmose \u2013 Eine Bestandsaufnahme unter deutschsprachigen Ophthalmologen. Ophthalmologe 105(11):1023\u20131028","journal-title":"Ophthalmologe"},{"key":"1155_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","volume":"4","author":"A Vartak","year":"2016","unstructured":"Vartak\u00a0A, Sucheck\u00a0SJ (2016) Recent advances in subunit vaccine carriers. Vaccines 4:12","journal-title":"Vaccines"},{"key":"1155_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/pathogens7010025","volume":"7","author":"M Wallon","year":"2018","unstructured":"Wallon\u00a0M, Peyron\u00a0F (2018) Congenital Toxoplasmosis: a plea for a\u00a0neglected disease. Pathogens 7:25","journal-title":"Pathogens"},{"key":"1155_CR64","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/infdis\/jiy211","volume":"218","author":"JL Wang","year":"2018","unstructured":"Wang\u00a0JL, Li\u00a0TT, Elsheikha\u00a0HM, Chen\u00a0K, Cong\u00a0W, Yang\u00a0WB, Bai\u00a0MJ, Huang\u00a0SY, Zhu\u00a0XQ (2018) Live attenuated Pru:\u0394cdpk2 strain of Toxoplasma gondii protects against acute, chronic, and congenital toxoplasmosis. J\u00a0Infect Dis 218:768\u2013777","journal-title":"J Infect Dis"},{"key":"1155_CR65","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3389\/fimmu.2017.00730","volume":"8","author":"JL Wang","year":"2017","unstructured":"Wang\u00a0JL, Elsheikha\u00a0HM, Zhu\u00a0WN, Chen\u00a0K, Li\u00a0TT, Yue\u00a0DM, Zhang\u00a0XX, Huang\u00a0SY, Zhu\u00a0XQ (2017) Immunization with Toxoplasma gondii GRA17 deletion mutant induces partial protection and survival in challenged mice. Front Immunol 8:730","journal-title":"Front Immunol"},{"key":"1155_CR66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/vaccines8010016","volume":"8","author":"L Wang","year":"2020","unstructured":"Wang\u00a0L, Tang\u00a0D, Yang\u00a0C, Yang\u00a0J, Fang\u00a0R (2020) Toxoplasma gondii ADSL knockout provides excellent immune protection against a\u00a0variety of strains. Vaccines 8:16","journal-title":"Vaccines"},{"key":"1155_CR67","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3389\/fmicb.2019.01875","volume":"10","author":"WB Yang","year":"2019","unstructured":"Yang\u00a0WB, Wang\u00a0JL, Gui\u00a0Q, Zou\u00a0Y, Chen\u00a0K, Liu\u00a0Q, Liang\u00a0QL, Zhu\u00a0XQ, Zhou\u00a0DH (2019) Immunization with a\u00a0live-attenuated RH:\u0394NPT1 strain of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice. Front Microbiol 10:1875","journal-title":"Front Microbiol"},{"key":"1155_CR68","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/1751-7915.13668","volume":"13","author":"J Yang","year":"2020","unstructured":"Yang\u00a0J, Yang\u00a0C, Qian\u00a0J, Li\u00a0F, Zhao\u00a0J, Fang\u00a0R (2020) Toxoplasma gondii \u03b1\u2011amylase deletion mutant is a\u00a0promising vaccine against acute and chronic toxoplasmosis. Microb Biotechnol 13:2057\u20132069","journal-title":"Microb Biotechnol"},{"key":"1155_CR69","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/vaccines8040731","volume":"8","author":"Z Yu","year":"2020","unstructured":"Yu\u00a0Z, Zhou\u00a0T, Luo\u00a0Y, Dong\u00a0L, Li\u00a0C, Liu\u00a0J, Luo\u00a0J, Yan\u00a0R, Xu\u00a0L, Song\u00a0X, Li\u00a0X (2020) Modulation effects of Toxoplasma gondii histone H2A1 on murine macrophages and encapsulation with polymer as a vaccine candidate. Vaccines 8:731","journal-title":"Vaccines"},{"issue":"10","key":"1155_CR70","first-page":"A-446\/B-399\/C-3","volume":"110","author":"V Zylka-Menhorn","year":"2013","unstructured":"Zylka-Menhorn\u00a0V (2013) Toxoplasmose-Test: Argumente f\u00fcr ein Screening. Dtsch Arztebl 110(10):A-446\/B-399\/C-399","journal-title":"Dtsch Arztebl"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01155-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01155-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01155-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T14:19:40Z","timestamp":1725718780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01155-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01155-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"type":"print","value":"0020-9554"},{"type":"electronic","value":"1432-1289"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"assertion":[{"value":"23 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Y.\u00a0Borkens gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}